Peptide Regulation
Explore peptide research and guides on peptide regulation.
How the EMA Regulates Peptide Drugs in Europe
The EMA's 2026 synthetic peptide guideline reshapes European peptide drug approval. How the centralized procedure works and where EMA and FDA rules diverge.
Peptide RegulationHow the FDA Regulates Peptides: Full Framework
The FDA regulates peptides through drug approvals, compounding pharmacy oversight, and the category classification system. Here is how the full framework works.
Peptide RegulationPeptide Importation Laws Explained
Importing peptides into the US, Australia, UK, and EU involves FDA rules, customs seizure risk, and personal importation limits. What each jurisdiction allows.
Peptide RegulationPeptide Regulation: US, EU, UK, Australia Compared
How the FDA, EMA, MHRA, and TGA regulate peptide drugs differently, from approval pathways to compounding rules. A full jurisdiction-by-jurisdiction guide.
Peptide RegulationResearch-Grade Peptides and Human Use
Research peptides labeled 'not for human use' exist in a legal gray area. What the law says, why quality varies wildly, and what changed in 2026.
Peptide RegulationRFK Jr Peptide Reclassification: What It Means
RFK Jr. announced 14 peptides moving from FDA Category 2 back to Category 1 on Feb 27, 2026. What changed, what didn't, and what it means for access.
Peptide RegulationFDA Peptide Restrictions: The 2023-2024 Timeline
A complete timeline of how the FDA restricted 19 peptides from compounding pharmacies in 2023-2024, which ones were reversed, and what the 2026 reclassification means.